Starling Oncology (STLN) Stock Price, News & Analysis
Company Description
Starling Oncology (NASDAQ: STLN) is classified in the medical care facilities industry within the Services-offices & Clinics of Doctors of Medicine sector and carries a market capitalization of $608.4M, ranking #3,464 among all listed U.S. companies by market cap.
STLN has declined 5.8% over the past week. Shares last traded at $5.97.
For FY2025, Starling Oncology reported revenue of $502.7M and diluted earnings per share of -$0.54.
This page collects what Stock Titan holds for STLN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Starling Oncology (STLN) stock last closed at $5.97. Over the past week, the stock has lost 5.8%. At a market capitalization of $608.4M, STLN is classified as a small-cap stock with approximately 101.9M shares outstanding.
STLN Rankings
Latest News
Starling Oncology has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include earnings. View all STLN news →
SEC Filings
Starling Oncology has filed 4 recent SEC filings, including 2 Form 8-K, 1 Form 4, 1 Form 144. The most recent filing was submitted on September 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all STLN SEC filings →
Insider Radar
Insider selling at Starling Oncology over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
Starling Oncology generated $502.7M in revenue in FY2025, and operating income reached -$36.1M (-7.2% operating margin). Diluted earnings per share stood at -$0.54. The company generated -$24.6M in operating cash flow. With a current ratio of 1.59, the balance sheet reflects a strong liquidity position.
Upcoming Events
Wells Fargo fireside chat
Starling Oncology has 1 upcoming scheduled event. The next event, "Wells Fargo fireside chat", is scheduled for September 8, 2026 (in 5 days). Investors can track these dates to stay informed about potential catalysts that may affect the STLN stock price.
Short Interest History
Days to Cover History
STLN Company Profile & Sector Positioning
Starling Oncology (STLN) operates in the Medical Care Facilities industry within the broader Services-offices & Clinics of Doctors of Medicine sector and is listed on the NASDAQ. In monthly performance, the stock ranks #846 among all tracked companies.